ClinicalTrials.Veeva

Menu

Early Life Exposures Among Children With Sickle Cell Disease

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Not yet enrolling

Conditions

Breastfeeding
Sickle Cell Disease
Adverse Childhood Experiences

Treatments

Other: Observation
Behavioral: Breastfeeding support group

Study type

Interventional

Funder types

Other

Identifiers

NCT05377372
IRB-300003639

Details and patient eligibility

About

This study is being conducted to determine the relationship between early childhood exposures, such as Adverse Childhood Experiences, Social Determinants of Health and nutrition/breastfeeding, among children with sickle cell disease, and behavioral interventions aimed to reshape psychological resilience and lifestyle factors towards positive health outcomes.

Full description

During year 3 of the award period, 20 mother-infant dyads will be randomly assigned to either a community-based breastfeeding support group or observation. Acceptability to enrollment, intervention adherence for at least 6 months and preliminary effectiveness will be captured. Biomarkers of inflammation, development of asthma and incidences of pain and/or acute chest syndrome will be compared among the intervention and control groups.

Enrollment

20 estimated patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • mother of infant with sickle cell disease
  • resides within the city of Birmingham, Alabama or in close proximity

Exclusion criteria

  • prescribed teratogenic medications
  • no/limited internet access

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20 participants in 2 patient groups

Breastfeeding Intervention Group
Experimental group
Description:
Ten mother-infant dyads will be recruited to a six-month, community-based intervention aimed to promote sustained breastfeeding for at least six months among mothers of infants with sickle cell disease. The intervention will include an online, social media-based support group, online educational modules, monthly in-person educational sessions, access to free breast pump rentals, and monthly peer-led home visits by certified Vanderbilt-affiliated Maternal Infant Health Outreach Specialists. We obtain whole blood specimens for analysis of oxidative stress and inflammation at 3, 6, 12 and 24 months.
Treatment:
Behavioral: Breastfeeding support group
Observation Group
Other group
Description:
A 24 month observation of 10 mother-infant dyads affected by sickle cell disease that initiate breastfeeding. These dyads will observed for breastfeeding exclusivity/dosage and duration. We obtain whole blood specimens for analysis of oxidative stress and inflammation at 3, 6, 12 and 24 months.
Treatment:
Other: Observation

Trial contacts and locations

1

Loading...

Central trial contact

Brandi M Pernell, DNP, MSPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems